Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What's the Buzz About Hydroxynorketamine? Is It the History, the Story, the Debate, or the Promise?

Literature DB >> 28317551

What's the Buzz About Hydroxynorketamine? Is It the History, the Story, the Debate, or the Promise?

Chadi G Abdallah¹.

Abstract

Entities: Chemical Disease Gene Species

Year: 2017 PMID： 28317551 PMCID： PMC5484143 DOI： 10.1016/j.biopsych.2017.01.002

Source DB: PubMed Journal: Biol Psychiatry ISSN： 0006-3223 Impact factor: 13.382

× No keyword cloud information.

9 in total

1. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.

Authors: Nanxin Li; Boyoung Lee; Rong-Jian Liu; Mounira Banasr; Jason M Dwyer; Masaaki Iwata; Xiao-Yuan Li; George Aghajanian; Ronald S Duman
Journal: Science Date: 2010-08-20 Impact factor: 47.728

2. Antidepressant effects of ketamine in depressed patients.

Authors: R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal: Biol Psychiatry Date: 2000-02-15 Impact factor: 13.382

3. Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine.

Authors: Panos Zanos; Ruin Moaddel; Patrick J Morris; Irving W Wainer; Edson X Albuquerque; Scott M Thompson; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal: Biol Psychiatry Date: 2016-09-30 Impact factor: 13.382

4. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.

Authors: Carlos A Zarate; Nancy Brutsche; Gonzalo Laje; David A Luckenbaugh; Swarajya L Vattem Venkata; Anuradha Ramamoorthy; Ruin Moaddel; Irving W Wainer
Journal: Biol Psychiatry Date: 2012-04-18 Impact factor: 13.382

Review 5. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression.

Authors: P Skolnick; R T Layer; P Popik; G Nowak; I A Paul; R Trullas
Journal: Pharmacopsychiatry Date: 1996-01 Impact factor: 5.788

Review 6. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.

Authors: Chadi G Abdallah; Thomas G Adams; Benjamin Kelmendi; Irina Esterlis; Gerard Sanacora; John H Krystal
Journal: Depress Anxiety Date: 2016-04-06 Impact factor: 6.505

7. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors: Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal: Biol Psychiatry Date: 2007-07-23 Impact factor: 13.382

8. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors: Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal: Nature Date: 2011-06-15 Impact factor: 49.962

9. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

Authors: Panos Zanos; Ruin Moaddel; Patrick J Morris; Polymnia Georgiou; Jonathan Fischell; Greg I Elmer; Manickavasagom Alkondon; Peixiong Yuan; Heather J Pribut; Nagendra S Singh; Katina S S Dossou; Yuhong Fang; Xi-Ping Huang; Cheryl L Mayo; Irving W Wainer; Edson X Albuquerque; Scott M Thompson; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal: Nature Date: 2016-05-04 Impact factor: 49.962

9 in total

12 in total

1. Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression.

Authors: Ming-Fen Ho; Cristina Correia; James N Ingle; Rima Kaddurah-Daouk; Liewei Wang; Scott H Kaufmann; Richard M Weinshilboum
Journal: Biochem Pharmacol Date: 2018-04-03 Impact factor: 5.858

2. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.

Authors: Kai Zhang; Hidetoh Toki; Yuko Fujita; Min Ma; Lijia Chang; Youge Qu; Shingo Harada; Tetsuhiro Nemoto; Akiko Mizuno-Yasuhira; Jun-Ichi Yamaguchi; Shigeyuki Chaki; Kenji Hashimoto
Journal: Psychopharmacology (Berl) Date: 2018-09-13 Impact factor: 4.530

Review 3. Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.

Authors: Jaclyn N Highland; Panos Zanos; Lace M Riggs; Polymnia Georgiou; Sarah M Clark; Patrick J Morris; Ruin Moaddel; Craig J Thomas; Carlos A Zarate; Edna F R Pereira; Todd D Gould
Journal: Pharmacol Rev Date: 2021-04 Impact factor: 25.468

4. Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment.

Authors: Chadi G Abdallah; Christopher L Averill; Ramiro Salas; Lynnette A Averill; Philip R Baldwin; John H Krystal; Sanjay J Mathew; Daniel H Mathalon
Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2017-10

5. (2R,6R)-hydroxynorketamine exerts mGlu₂ receptor-dependent antidepressant actions.

Authors: Panos Zanos; Jaclyn N Highland; Brent W Stewart; Polymnia Georgiou; Carleigh E Jenne; Jacqueline Lovett; Patrick J Morris; Craig J Thomas; Ruin Moaddel; Carlos A Zarate; Todd D Gould
Journal: Proc Natl Acad Sci U S A Date: 2019-03-13 Impact factor: 11.205

10. Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.

Authors: Yukihiko Shirayama; Kenji Hashimoto
Journal: Int J Neuropsychopharmacol Date: 2018-01-01 Impact factor: 5.176